Incannex Healthcare Inc. Basic Shares Outstanding (Weighted Average)
Incannex Healthcare Inc. (IXHL) reported Basic Shares Outstanding (Weighted Average) of 12.35 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-15
- Incannex Healthcare Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 12.35M shares, a 1786.94% increase year-over-year.
- Incannex Healthcare Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 349.46M shares, a 1882.84% increase year-over-year.
- Incannex Healthcare Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 310.31M shares, a 1658.84% increase year-over-year.
- Incannex Healthcare Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 135.99M shares, a 698.18% increase year-over-year.
- Incannex Healthcare Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 34.45M shares, a 113.15% increase from fiscal 2024.
- Incannex Healthcare Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 16.16M shares, a 5.07% increase from fiscal 2023.
- Incannex Healthcare Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 15.38M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | 12.35M shares 10-Q · filed 2026-05-15 | 180.91M shares derived: average of 2 quarters · filed 2026-05-15 | 11.45M shares 10-Q · filed 2026-05-15 | 202.03M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | 349.46M shares 10-Q · filed 2026-02-13 | 329.98M shares 10-Q · filed 2026-02-13 | 265.26M shares derived: average of 3 quarters · filed 2026-02-13 | 199.11M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2025-09-30 | 310.31M shares 10-Q · filed 2025-11-14 | 223.15M shares derived: average of 2 quarters · filed 2025-11-14 | 148.99M shares derived: average of 3 quarters · filed 2026-05-15 | 116.15M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2025-06-30 | 135.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | 68.32M shares derived: average of 2 quarters · filed 2026-05-15 | 51.42M shares derived: average of 3 quarters · filed 2026-05-15 | 34.45M shares 10-K · filed 2025-09-29 | ||
| 2025-03-31 | 654.42K shares 10-Q · filed 2026-05-15 | 19.63M shares 10-Q · filed 2025-05-15 | 9.14M shares derived: average of 2 quarters · filed 2026-05-15 | 607.96K shares 10-Q · filed 2026-05-15 | 18.24M shares 10-Q · filed 2025-05-15 | 13.24M shares derived: average of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 17.62M shares 10-Q · filed 2026-02-13 | 17.56M shares 10-Q · filed 2026-02-13 | 17.44M shares derived: average of 3 quarters · filed 2026-02-13 | 17.04M shares derived: average of 4 quarters · filed 2026-02-13 | ||
| 2024-09-30 | 17.64M shares 10-Q · filed 2025-11-14 | 17.34M shares derived: average of 2 quarters · filed 2025-11-14 | 16.85M shares derived: average of 3 quarters · filed 2025-11-14 | 16.61M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 17.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | 16.46M shares derived: average of 2 quarters · filed 2025-09-29 | 16.26M shares derived: average of 3 quarters · filed 2025-09-29 | 16.16M shares 10-K · filed 2025-09-29 | ||
| 2024-03-31 | 15.87M shares 10-Q · filed 2025-05-15 | 15.87M shares derived: average of 2 quarters · filed 2025-05-15 | 15.87M shares 10-Q · filed 2025-05-15 | 15.87M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | 15.87M shares 10-Q · filed 2025-02-14 | 15.87M shares 10-Q · filed 2025-02-14 | 15.87M shares derived: average of 3 quarters · filed 2025-02-14 | 15.87M shares 10-Q · filed 2024-02-14 | ||
| 2023-09-30 | 15.87M shares 10-Q · filed 2024-11-14 | 15.87M shares derived: average of 2 quarters · filed 2024-11-14 | 15.87M shares derived: average of 3 quarters · filed 2024-11-14 | 15.75M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 15.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | 15.87M shares derived: average of 2 quarters · filed 2024-09-30 | 15.71M shares derived: average of 3 quarters · filed 2024-09-30 | 15.38M shares 10-K · filed 2024-09-30 | ||
| 2023-03-31 | 15.87M shares 10-Q · filed 2024-05-15 | 15.64M shares derived: average of 2 quarters · filed 2024-05-15 | 15.22M shares 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 15.40M shares 10-Q · filed 2024-02-14 | 14.90M shares 10-Q · filed 2024-02-14 | 14.90M shares 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |